Bucking the One-Time Trendsetter


San Francisco - According to an analysis of data from more than 700 patients, a new nonsteroid treatment for atopic dermatitis is a safe, effective, and cost-effective alternative to conventional therapy for the chronic, relapsing inflammatory skin disease that primarily affects infants and children.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.